Hantz Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Buy |
5,259
+769
| +17% | +$35.5K | ﹤0.01% | 592 |
|
|
2025
Q1 | $274K | Buy |
4,490
+70
| +2% | +$4.27K | ﹤0.01% | 543 |
|
|
2024
Q4 | $250K | Buy |
4,420
+71
| +2% | +$4.02K | ﹤0.01% | 546 |
|
|
2024
Q3 | $225K | Sell |
4,349
-106
| -2% | -$5.48K | ﹤0.01% | 556 |
|
|
2024
Q2 | $185K | Buy |
4,455
+1,671
| +60% | +$69.4K | ﹤0.01% | 569 |
|
|
2024
Q1 | $151K | Sell |
2,784
-154
| -5% | -$8.35K | ﹤0.01% | 584 |
|
|
2023
Q4 | $151K | Sell |
2,938
-202
| -6% | -$10.4K | ﹤0.01% | 576 |
|
|
2023
Q3 | $182K | Sell |
3,140
-95,774
| -97% | -$5.55M | ﹤0.01% | 553 |
|
|
2023
Q2 | $6.33M | Buy |
98,914
+663
| +0.7% | +$42.4K | 0.16% | 176 |
|
|
2023
Q1 | $6.81M | Buy |
98,251
+1,332
| +1% | +$92.3K | 0.19% | 160 |
|
|
2022
Q4 | $6.97M | Buy |
96,919
+3,279
| +4% | +$236K | 0.21% | 148 |
|
|
2022
Q3 | $6.66M | Buy |
93,640
+2,014
| +2% | +$143K | 0.23% | 139 |
|
|
2022
Q2 | $7.06M | Buy |
91,626
+3,656
| +4% | +$282K | 0.24% | 131 |
|
|
2022
Q1 | $6.42M | Buy |
87,970
+5,086
| +6% | +$371K | 0.19% | 158 |
|
|
2021
Q4 | $5.17M | Buy |
82,884
+3,558
| +4% | +$222K | 0.15% | 177 |
|
|
2021
Q3 | $4.69M | Buy |
79,326
+39,829
| +101% | +$2.36M | 0.15% | 176 |
|
|
2021
Q2 | $2.64M | Buy |
39,497
+3,477
| +10% | +$232K | 0.1% | 217 |
|
|
2021
Q1 | $2.27M | Buy |
36,020
+277
| +0.8% | +$17.5K | 0.09% | 224 |
|
|
2020
Q4 | $2.22M | Buy |
35,743
+176
| +0.5% | +$10.9K | 0.1% | 215 |
|
|
2020
Q3 | $2.14M | Buy |
+35,567
| New | +$2.14M | 0.11% | 199 |
|